DACARBAZINE 200 MG POWDER OR LYOPHILIZED PHARMACEUTICAL FAMILY 1000022067

This tender, originating from Chile and available on the chile_mercadopublico platform, is for "Dacarbazine 200 mg Powder or Lyophilized Pharmaceutical Family 1000022067". The contracting authority is seeking to procure Dacarbazine, an antineoplastic chemotherapy drug, in a 200 mg dosage form, available as either a powder for reconstitution or a lyophilized product. The reference number "FAM 1000022067" likely pertains to a specific pharmaceutical family or product code within the Chilean health system. This procurement is critical for providing essential cancer treatment to patients. Bidders are expected to be authorized pharmaceutical suppliers or manufacturers capable of providing high-quality, registered medications. Key requirements will include adherence to stringent pharmaceutical quality standards (e.g., GMP), proper packaging, labeling, and storage conditions, as well as compliance with all relevant national regulations for pharmaceutical importation and distribution. The tender documents will detail the specific quantity required, delivery timelines, and any specific formulation or brand preferences.

This is a services contract in the health and medical services, trade and industry and general supplies sectors. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.